Skip to main content

Table 3 Frequencies of hypertension, dyslipidemia, and adequacy of treatment in participants with and without T2D

From: Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies

 

Type 2 diabetes

Non-type 2 diabetes

Men, n = 706

Women, n = 581

All, n = 1287

All, n = 13785

Complete cases hypertension

n(cc) = 698

n(cc) = 572

n(cc) = 1270

n(cc) = 13443

No hypertension

135 (19.3)

87 (15.2)

222 (17.5)

5509 (41.0)◯

Hypertension

563 (80.7)

485 (84.8)

1048 (82.5)

7934 (59.0)◯

(1) Controlled treated, BP < 140/90

97 (13.9)

143 (25.0)*

240 (18.9)

1357 (10.1)◯

(2) Uncontrolled treated, > = 140/90

271 (38.8)

249 (43.5)*

520 (40.9)

2495 (18.6)◯

(3) Known, but not treated, > = 140/90

51 (7.3)

34 (5.9)

85 (6.7)

1178 (8.8)◯

(4) Unknown, > = 140/90

144 (20.6)

59 (10.3)*

203 (16.0)

2904 (21.6)◯

Untreated or insufficiently treated (groups 2, 3, 4)

466 (66.8)

342 (59.8)*

808 (63.6)

6577 (48.9) ◯

GNHIES98

101 (72.1)

94 (67.6)

195 (69.9)

1904 (61.4)◯

CARLA

72 (75.8)

42 (53.9)*

114 (65.9)

668 (55.3)◯

DHS

39 (75.0)

24 (68.6)

63 (72.4)

503 (63.3)

KORA

49 (61.3)

37 (56.9)

86 (59.3)

898 (39.3)◯

HNR

107 (52.7)

66 (49.6)

173 (51.5)

1504 (36.8)◯

SHIP

98 (76.6)

80 (65.0)*

178 (70.9)

1110 (55.7)◯

Complete cases dyslipidemia

n(cc) = 639

n(cc) = 522

n(cc) = 1161

n(cc) =12451

No dyslipidemia

277 (43.4)

248 (47.5)

525 (45.2)

8004 (64.3)◯

Dyslipidemia

362 (56.7)

274 (52.5)

636 (54.8)

4447 (35.7)◯

(1) Controlled treated , TC/HDL <5

65 (10.2)

78 (14.9)

143 (12.3)

861 (6.9)◯

(2) Uncontrolled treated, > = 5

43 (6.7)

41 (7.9)

84 (7.2)

299 (2.4)◯

(3) Known, but not treated, > = 5

114 (17.8)

85 (16.3)

199 (17.1)

1535 (12.3)◯

(4) Unknown, > = 5

140 (21.9)

70 (13.4)*

210 (18.1)

1752 (14.1)◯

Untreated or insufficiently treated (groups 2, 3, 4)

297 (46.5)

196 (37.6)*

493 (42.5)

3586 (28.8) ◯

GNHIES98

73 (54.9)

62 (48.8)

135 (51.9)

1040 (35.3)◯

CARLA

34 (35.8)

18 (23.1)

52 (30.1)

280 (23.3)

(DHS)◖

(15 (31.3))

(7 (22.6))

(22 (27.9)

(105 (14.7)

KORA

39 (48.8)

24 (38.1)

63 (44.1)

675 (29.7)◯

HNR

87 (42.9)

41 (31.1)*

128 (38.2)

996 (24.5)◯

SHIP

64 (50.0)

51 (41.5)

115 (45.8)

600 (30.4)◯

  1. BP: blood pressure, TC: total cholesterol, HDL: high density lipoprotein n(cc) = number of complete cases concerning variables used for these statistics, i.e. physician's diagnosis, medication intake and BP measurement or lipid measurement, respectively.
  2. *Test of the difference between T2D men and T2D women, p <0.05.
  3. ◯Test of the difference between all T2D subjects and all non-T2D subjects, p < 0.05.
  4. ◖without consideration of physician's diagnosis because this variable was missing in DHS.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840